Skip to main content

ADAR1 Capital Management, LLC

Position in NVO — Novo Nordisk A S

CIK 1940272 AUSTIN, TX

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,294,380
+$81,630 QoQ
Shares Held
27,000
-18.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#462
of 1,348 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Jun 30, 2026
CallValue
$623,220
CallShares
13,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $14,801,650 across 7 Drug Manufacturers - General names. NVO ranks #4 (8.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVO
Novo Nordisk A S
This page
27,000 $1,294,380

All Filings in NVO

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,294,380 27,000
2026-06-30 $623,220 13,000
2026-03-31 $1,212,750 33,000
2026-03-31 $477,750 13,000
2024-09-30 $1,190,700 10,000
2024-09-30 $2,381,400 20,000
2024-06-30 $28,548 200
2024-03-31 $12,840 100
2023-12-31 $656,907 6,350